arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

MANNATECH INC

MTEX
$7.51 ▼ -0.59 (-7.28%) at close
Materials ·Medicinal Chemicals & Botanical Products ·USMedicinal Chemicals & Botanical Products
73 Visible periods
34 Metrics
Peer-ranked Benchmarks
Price Chart
59
Health
Fair
Moderately Bullish
auto_awesome

Analytical Summary

MANNATECH INC demonstrates solid fundamentals with strength in Return on Common Equity (%). However, watch Profit Margin (%) which shows concerning trends. Overall, the data suggests a moderately positive outlook with manageable risks.

Market Cap $14.5M
Dividend Yield —
Revenue Growth 3.8% ↗
Op. Margin 3.7% ↗
ROIC -39.2% ↘
FCF / Share $-0.42 ↘
Trailing P/E 14.2x
Price / Book —
FCF Yield —
Debt / Equity -0.55
info Valuation on last close. End-of-day price, Sep 23, 2026.

73-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$26.65M
↑ +3.8% —
Net Income Profit after all expenses
$950.00K
— 0.0% —
Operating Margin Operating profit as % of sales
3.7%
↑ +618.4% 27th
FCF / Share Free cash flow per share
$-0.42
↑ +79.5% —
Long-Term Debt Long-term obligations
$2.75M
— 0.0% —
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
19
Returns ↑
100
Financial Health
73
Cash Quality ↓
32

Dividend History

Dividend / share · sourced from SEC filings
$0.20 Latest / share
+0.0% YoY
+8.1% 7-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 20 years · 73 quarters